{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:53Z","timestamp":1792269533216,"version":"4.4.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.7759\/cureus.114199","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:23:07Z","timestamp":1786281787000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Dupilumab-Associated Psoriasis Flare After Switching From Ustekinumab for Biopsy-Proven Eczematous Dermatitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Doaa","family":"AlAwadhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"AlQusaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawziah","family":"AlRujaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"AlSharhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"AlShatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alflaij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Alobaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suad","family":"Alassaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemah","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munirah F","family":"AlEnezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su Z","year":"2023","unstructured":"Su Z, Zeng YP. Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review. Dermatology. 2023, 239:646-57. 10.1159\/000530608","journal-title":"Dermatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13846","article-title":"Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis","volume":"63","author":"Casale F","year":"2022","unstructured":"Casale F, Nguyen C, Dobry A, Smith J, Mesinkovska NA. Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis. Australas J Dermatol. 2022, 63:394-7. 10.1111\/ajd.13846","journal-title":"Australas J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.1625","article-title":"Defining on-treatment remission in plaque psoriasis: a consensus statement from the National Psoriasis Foundation","volume":"161","author":"Armstrong AW","year":"2025","unstructured":"Armstrong AW, Gondo GC, Merola JF, et al.. Defining on-treatment remission in plaque psoriasis: a consensus statement from the National Psoriasis Foundation. JAMA Dermatol. 2025, 161:863-9. 10.1001\/jamadermatol.2025.1625","journal-title":"JAMA Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/dermatopathology12020017","article-title":"Erythrodermic psoriasis in the context of emerging triggers: insights into dupilumab-associated and COVID-19-induced psoriatic disease","volume":"12","author":"Fadel A","year":"2025","unstructured":"Fadel A, Nithura J, Saadoon ZF, et al.. Erythrodermic psoriasis in the context of emerging triggers: insights into dupilumab-associated and COVID-19-induced psoriatic disease. Dermatopathology (Basel). 2025, 12:17. 10.3390\/dermatopathology12020017","journal-title":"Dermatopathology (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16764","article-title":"Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: a retrospective study","volume":"50","author":"Napolitano M","year":"2023","unstructured":"Napolitano M, Fabbrocini G, Patruno C. Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: a retrospective study. J Dermatol. 2023, 50:880-7. 10.1111\/1346-8138.16764","journal-title":"J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0664","article-title":"Unintended consequences of immune therapy for immune-mediated diseases: paradoxical psoriasis and dupilumab-associated musculoskeletal syndrome","volume":"51","author":"Wallace EB","year":"2024","unstructured":"Wallace EB, Hughes CD, Menon B, Kirkham B. Unintended consequences of immune therapy for immune-mediated diseases: paradoxical psoriasis and dupilumab-associated musculoskeletal syndrome. J Rheumatol. 2024, 51:70-3. 10.3899\/jrheum.2024-0664","journal-title":"J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.70503","article-title":"Treatment-associated phenotype switching between psoriasis and atopic dermatitis","author":"Torres T","year":"2026","unstructured":"Torres T, Valenti M, Balato A, et al.. Treatment-associated phenotype switching between psoriasis and atopic dermatitis. J Eur Acad Dermatol Venereol. 2026, 10.1111\/jdv.70503","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/518587-severe-dupilumab-associated-psoriasis-flare-after-switching-from-ustekinumab-for-biopsy-proven-eczematous-dermatitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T13:23:08Z","timestamp":1786281788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/518587-severe-dupilumab-associated-psoriasis-flare-after-switching-from-ustekinumab-for-biopsy-proven-eczematous-dermatitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.114199","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}